Your browser doesn't support javascript.
loading
Sevoflorano como coadyuvante en la sedación durante ventilación mecánica en pacientes médicos de Unidad de Cuidados Intensivos: resultados preliminares en una serie de casos / Sevoflorane as adjuvant for sedation during mechanical ventilation in intensive care unit medical patients: Preliminary results of a series of cases
Lopez-Ramos, Jose M; Gômez-Sainz, Juan J; Manzano-Canalechevarria, Ana; Aguilera-Celorrio, Luciano.
  • Lopez-Ramos, Jose M; Basurto University Hospital. Resident 4th Anesthesia and Resuscitation Course. ES
  • Gômez-Sainz, Juan J; Basurto University Hospital. Resident 4th Anesthesia and Resuscitation Course. ES
  • Manzano-Canalechevarria, Ana; Basurto University Hospital. Resident 4th Anesthesia and Resuscitation Course. ES
  • Aguilera-Celorrio, Luciano; Basurto University Hospital. Resident 4th Anesthesia and Resuscitation Course. ES
Rev. colomb. anestesiol ; 44(1): 52-57, Jan.-Mar. 2016. ilus
Article in English | LILACS, COLNAL | ID: lil-776312
ABSTRACT

Objective:

To disclose our preliminary experience in inhalation sedation with sevoflorane in a standardized manner using the Anesthetic Conserving Device in intubated, critically ill patients in our ICU. Patients It has been used in nine cases of adult patients, six men and three women, over 24 months.

Results:

A proper implementation of the protocol by physicians and the nursing staff has been achieved, meeting the goals established for sedation (RASS 0, -2) free of hepatic or renal adverse outcomes or side effects.

Conclusions:

In our limited experience, adjuvant inhalation sedation with sevoflorane in the ICU is safe and complementary to the use of intravenous drugs such as propofol, remifentanil and midazolam, which are currently commonly used to achieve goal-directed sedation.
RESUMEN

Objetivo:

Explicar nuestra experiencia preliminar en la utilización de sedación inhalatoria de manera estandarizada con sevoflorano mediante dispositivo Anesthetic Conserving Device en pacientes críticos intubados en nuestra UCI. Pacientes se ha utilizado en 9 casos, en pacientes adultos, 6 hombres y 3 mujeres, durante un periodo de 24 meses.

Resultados:

se ha conseguido una adecuada implantación del protocolo por parte de médicos y personal de enfermería, logrando los objetivos de sedación fijados en un primer momento (RASS 0, -2) y sin obtener resultados adversos ni efectos secundarios a nivel hepático y/o renal.

Conclusiones:

en nuestra limitada experiencia, la sedación inhalatoria con sevoflorano coadyuvante en UCI es una técnica segura y complementaria al uso de fármacos intravenosos, como propofol, remifentanilo y midazolam, utilizados habitualmente, para lograr una sedación guiada por objetivos.
Subject(s)

Full text: Available Index: LILACS (Americas) Limits: Humans Language: English Journal: Rev. colomb. anestesiol Journal subject: Anesthesiology Year: 2016 Type: Article Affiliation country: Spain Institution/Affiliation country: Basurto University Hospital/ES

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Limits: Humans Language: English Journal: Rev. colomb. anestesiol Journal subject: Anesthesiology Year: 2016 Type: Article Affiliation country: Spain Institution/Affiliation country: Basurto University Hospital/ES